Cold Spring Harbor, NY, United States of America

Christof Fellmann

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christof Fellmann: Innovator in RNA Interference Technology

Introduction

Christof Fellmann is a prominent inventor based in Cold Spring Harbor, NY (US). He has made significant contributions to the field of RNA interference (RNAi) technology. His innovative work has led to advancements that enhance our understanding of gene regulation and therapeutic applications.

Latest Patents

Fellmann holds a patent for "High throughput methods for functionally determining RNA interference efficiency." This patent describes a single construct that combines a sequence encoding an RNAi molecule, a sequence encoding a reporter, and a target sequence specific for the RNAi molecule. The construct is designed to determine the potency of the encoded RNAi molecule in a direct and unbiased manner. The results from this invention can inform the design of potent RNAi molecules and extend to various applications, including the generation of tiled libraries, large-scale validation of RNAi molecules, experimental comparison of design algorithms, and investigation of RNAi biology in target site mutagenesis assays. He has 1 patent to his name.

Career Highlights

Fellmann is affiliated with Cold Spring Harbor Laboratory, where he conducts his research. His work has been instrumental in advancing the field of RNAi, providing tools and methodologies that enhance the efficiency of gene silencing techniques.

Collaborations

Fellmann has collaborated with notable scientists such as Scott William Lowe and Gregory J Hannon. These collaborations have further enriched his research and contributed to the broader scientific community.

Conclusion

Christof Fellmann's contributions to RNA interference technology exemplify the impact of innovative thinking in the field of genetics. His patent and research efforts continue to pave the way for advancements in gene regulation and therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…